摘要
骨髓增生异常综合征(MDS)是一组多步骤累及多基因异常变化而导致的具有高度异质性的造血系统恶性克隆性疾病。主要表现为骨髓髓系细胞一系或多系发育异常,无效造血导致难治性贫血或全血细胞减少及演变为急性髓系白血病风险增高[1]。2008年WHO血液肿瘤分类系统将MDS列为五类主要髓系肿瘤之一。
出处
《中华医学杂志》
CAS
CSCD
北大核心
2015年第12期951-954,共4页
National Medical Journal of China
基金
国家科技重大专项子课题(2012XZ09303004-D01)
国家自然科学基金(81070404、81100389)
参考文献32
-
1Corey SJ, Minden MD, Barber DL, et al. Myelodysplastic syndromes: the complexity of stem-ceU diseases [ J ]. Nat Rev Cancer, 2007, 7(2) :118-129.
-
2Germing U, Aul C, Niemeyer CM, et al. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes [ J ]. Ann Hematol, 2008, 87 (9) :691- 699.
-
3Sharma SV, Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents [J]. Nat Rev Cancer, 2010, 10(4) :241-253.
-
4Matsuo Y, Minowada J. Human leukemia cell lines-clinical and theoretical significances[ J]. Hum Cell, 1988, 1 (3) :263-274.
-
5Racker FG, Sander S, Di~hner K, et al. Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations [ J ]. Leukemia, 2006, 20(6) :994-1001.
-
6Drexler HG, Dirks WG, Macleod RA. Many are called MDS cell lines: one is chosen[J]. Leuk Res, 2009, 33(8) :1011-1016.
-
7Minegishi N, Minegishi M, Tsuchiya S, et al. Erythropoietin- dependent induction of hemoglobin synthesis in a cytokine- dependent cell line M-TAT [ J ]. J Biol Chem, 1994, 269 (44) : 27700-27704.
-
8Mishima Y, Terui Y, Mishima Y, et al. New human myelodysplastic cell line, TER-3: G-CSF specific downregulation of Ca2 +/calmodulin-dependent protein kinase 1V [ J ]. J Cell Physiol, 2002, 191(2) :183-190.
-
9Tohyama K, Tsutani H, Ueda T, et al. Establishment and eharaeterizafion of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome [J]. Br J Haematol, 1994, 87(2) :235-242.
-
10Boultwood J, Fidler C, Strickson AJ, et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome[ J]. Blood, 2002, 99 (12) :4638-4641.
二级参考文献23
-
1Aauei CM, Flandrin P, Eloae FZ, et al. Intrinsic growth deficiencies of mesenchymal stromal ceils in myelodysplastic syndromes[ J]. Stem Ceils Dev, 2012,21:1604-1615.
-
2Walter M J, Shen D, Shao J, et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes [ J ]. Leukemia, 2013,27 : 1275-1282.
-
3Wegrzyn J, Lam JC, Karsan A. Mouse models of myelodysplastic syndromes[ J ]. Leuk Res, 2011,35 : 853-862.
-
4Lushnikova T, Bouska A, Odvody J, et al. Aging mice haveincreased chromosome instability that is exacerbated by elevated Mdm2 expression[ J]. Oncogene, 2011,30 : 4622-4631.
-
5Soulier J. Faneoni anemia[ J]. Hematology Am Soc Hematol Educ Program,2011,2011 : 492-497.
-
6Dickstein J, Senyuk V, Premanand K, et al. Methylation and silencing of miRNA-124 by EVIl and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome [ J ]. Proc Natl Acad Sci U S A, 2010,107: 9783-9788.
-
7Pronier E, Almire C, Mokrani H , et al. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethyleytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors[J]. Blood, 2011,118: 2551-2555.
-
8Eklund E. The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis [ J]. Crit Rev Oneog, 2011,16: 65-76.
-
9Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia [ J ]. Nature, 2010,464 : 852-857.
-
10Zhu DX, Fan L, Lu RN, et al. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia [ J]. Cancer Sci, 2012,103: 875-881.
同被引文献20
-
1王树娟,王冲,王伟琼,郝倩倩,刘延方.脂联素受体激动剂AdipoRon通过AMPK/自噬途径抗骨髓瘤细胞增殖[J].中国实验血液学杂志,2020,28(1):171-176. 被引量:7
-
2姚红霞,黄莉,林丽娥,吴从明,姚志明,王谷云,王华,饶若,符祥俊,唐瑞梅.原发性血小板增多症患者血小板功能指标的变化及其与血小板数量关系的研究[J].血栓与止血学,2010,16(1):21-23. 被引量:8
-
3张晓辉.细胞因子与骨髓增生异常综合征的治疗[J].临床血液学杂志,2011,24(6):638-641. 被引量:1
-
4罗静,叶兴伟,蒋文,周洪静,杨泽松,刘林,王利.阿糖胞苷诱导人MDS细胞株MUTZ-8细胞凋亡过程中活性氧水平的变化[J].第三军医大学学报,2012,34(15):1492-1495. 被引量:3
-
5刘天浩,陈运贤,钟雪云,钟立业,林旭滨,姚麟,赵洪云,欧瑞明,苏薇薇,徐培林.血小板生成素及血小板生成素Ⅱ对人血小板活化的影响[J].中国病理生理杂志,2001,17(5):415-417. 被引量:3
-
6吕君,朱鹏飞,刘艳民,曾庆磊,余祖江.黄芪多糖通过Wnt/β-catenin信号通路促进肝癌细胞凋亡研究[J].中草药,2018,49(21):5155-5160. 被引量:31
-
7孙运秀,薛寅凯,刘延军,朱鹏程,窦东伟,陈立波,程平,杨东.血小板膜糖蛋白CD61、CD62P在小鼠脓毒症炎性反应中的调控作用[J].中华实验外科杂志,2015,32(4):745-747. 被引量:5
-
8涂燕平,姚晓璐,曾黎峰,雷梦觉,王晓华,龚爱斌,魏伟荣,王凌玲,艾文伟,邬甦.同型半胱氨酸与H型高血压患者血小板活化的相关性及依那普利叶酸片的干预研究[J].中国心血管病研究,2015,13(8):727-730. 被引量:6
-
9梁颖,李冀,郭盛磊,李大然,徐放,蔡文辉.熟地黄多糖对荷瘤小鼠肿瘤组织Cyt-C及Caspase-3基因表达的影响[J].中医药信息,2017,34(3):24-27. 被引量:11
-
10管文敏,余卫.骨髓增生异常综合征的MRI研究进展[J].国际医学放射学杂志,2018,41(1):77-80. 被引量:5
引证文献2
-
1吴美,葛洪峰,楚海亮,杨世礼,周振霞.骨髓增生异常综合征止血功能的研究[J].血栓与止血学,2016,22(2):157-158.
-
2赵志芳,赵志英,杨艳敏,席亚男,刘泉.温补肾阳方通过ROS/p38 MAPK通路对骨髓增生异常综合征细胞株自噬及凋亡的影响[J].山西医科大学学报,2021,52(4):463-468.
-
1邵凤杰,王丽红.骨髓增生异常综合征20例分析[J].中国误诊学杂志,2010,10(18):4483-4483.
-
2徐泽锋,肖志坚.地西他滨治疗骨髓增生异常综合征临床应用分析[J].中国处方药,2013,11(3):40-42. 被引量:5
-
3左安兰.骨髓增生异常综合症免疫方面发病机制研究进展[J].哈尔滨医药,2010,30(3):59-60. 被引量:1
-
4郭辉.多发性骨髓瘤临床分析[J].内蒙古医学杂志,2008,40(4):489-490.
-
5王莉娟,王旭,潘敏,葛春莲,孟高乐.老年人骨髓增生异常综合征28例临床报告[J].武警医学,2001,12(7):417-418.
-
6张岚.骨髓增生异常综合征的治疗进展[J].中国煤炭工业医学杂志,2007,10(9):1007-1008.
-
7黄文荣,达万明.造血干细胞移植治疗白血病的某些进展[J].内科急危重症杂志,2005,11(3):109-111. 被引量:3
-
8邱丽君,庞华,司玉玲.36例骨髓增生异常综合征诊断分析[J].中国城乡企业卫生,2003(4):31-32.
-
9邵宗鸿.中高危骨髓增生异常综合征的治疗选择[J].中华血液学杂志,2012,33(7):508-509. 被引量:13
-
10刘尚勤,何莉,罗琳,马梓.骨髓增生异常综合征中西医结合治疗的可行性[J].中华临床医师杂志(电子版),2013,7(5):4-6. 被引量:2